(This is super-rapid pre-print on virological.org - other people will pick over this no doubt - but the openness of the data and quality of analysis from this group means this is super solid, and any updates on discussion likely to happen fast)
Two key take aways from this paper for me:
1. There is a big jump in number of changes - too big to be explainable with the natural progression over time. @arambaut and colleagues point out that similar big jumps have happened in immunocompromised patients treated via convalescent plasma + drugs
2. This means there are both a number of potential things that could have changed and that it might be that there is synergistic effects - one now needs to test out what things are different in the lab and then work through each one in turn if there is a difference.
The other complication to this is that the 69/70 deletion is present on this branch. This deletion is complex for a variety of reasons
1. Firstly it is recurrent. We have seen this globally in Lyon (but to stress - *just* this event not the whole strain) and in the Danish outbreak that ended up in Mink farms (again, *just* this change not the whole set).
It is unusual to have sequenced so many individuals where one has a slow(ish) moving mutation rate and recurrent mutation. This is what gives @EBIgoldman and colleagues some new headaches (should one collapse multiple observations of the same sequence in likelihood calcs?)
2. This site overlaps with primer sites for some widely used RT-PCR tests. To stress, nearly all RT-PCR tests use 3 (sometimes more!) sites to assess, so having one "drop out" as it is called is ok.
This sounds concerning at first glance but shouldn't be (this is why they do 3 sites!) and for sure the test site will be moved. However, it does mean we can see this in the RT-PCR testing itself.
Here is Tony Cox, @The_Soup_Dragon showing how this variant rose over time. Please note that early on the red line here is likely to be a mixture of viral versions which have this change, but then you can see it take off.
This means we've got the numbers for lineage displacement (not just growth), meaning scientists can be pretty confident that this version of the virus is growing.
The recurrent mutation of this virus is interesting, and this variant also shares a mutation with a South African strain that also came into the news for potential faster transmission - to stress, these are certainly different lineages.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Final thread in a series of 3 - what does this new variant mean for the next stages of the pandemic?
So - first off, if the biology has changed, we need to check all the biological and clinical parameters, some of them urgently. Most obviously do the vaccines work against them. There are good reasons to think this is v. likely which I outlined yesterday.
Briefly they are 1. The vaccine trials all happened with a mixture of different variants circulating (as happens everywhere - there's far more than this B.1.1.7 strain circulating). The fact all 3 work in this mixture is reassuring.
So - that was quite a twitter/media day for me, and welcome to my new followers; 3 threads coming up - introducing myself, explaining my background and COIs (this one); technical aspects of the new strain from my vantage; commentary on what is means for the future
(for the people who know me, skip the rest of this thread!)
A brief tweet portrait of me; I am deputy director general of @embl and co-direct (with Rolf Apweiler, not on twitter) one it's six sites, @emblebi which is based just south of Cambridge, UK.
New SARS_CoV_2 virus strain update. TL;DR - there is something to understand more, and it looks like the virus has tweaked its biology at least on transmissibility; Public health, scientists + surveillance systems are on it.
What do we know? Like all viruses SARS_CoV_2 changes - like typos in a manuscript that is endlessly retyped - and in fact this virus has a pretty pedestrian rate of typos. One version ("variant" or "strain") found in the south east England has a number of interesting properties
COVID in Europe - my perspective this bright, sunny day in London. As ever, the main group I feel I am talking to here are journalists, who have to write about COVID because... it effects our lives so much.
Context: I am an expert in genetics/computational biology; I know of experts in viral evolution, clinical trials, immunology, infectious epidemiology and chit-chat with them regularly. I have a COI that I am long standing consultant to Oxford Nanopore which makes a COVID test.
Reminder: SARS_CoV_2 is an infectious human virus which causes a nasty disease in a subset of people; some people die (even with the best medical treatment); others suffer a long term disease we are trying to understand.
Deep breath, my views on the SARS CoV2 Mutation story in London/South East. It's a fast moving story (at least for phylogeography); I'm a one step-away from experts, aiming here to provide some light.
Some background - like all viruses SARS-CoV-2 encodes its information in a nucleic acid, in SARS's case, RNA. This is simply a very long polymer made from 4 chemical subunits; the "long form" of these chemicals are too tedious to write down, so we give the 4 letters - A,C, U* + G
(the * is because in RNA one of the bases is Uracil - U - whereas as in DNA it is Thymine - T - basically for these purposes it doesn't matter and because one often does read outs in DNA not RNA letters, one uses T not U. One of these little "this is how it works, its a detail")
I know I am both late to this and also this is a US thing, but the whole Dr Biden shouldn't be a Dr because.... some sort of false pretences is insane and really stinks as well.
I wryly note the pride that Surgeons have in the UK that they are *not* addressed as Drs but rather Mr (does the US have this as well) which is a real inside medicine moment.
Obviously Doctor (from the latin, to teach) has always been broader than medicine and indeed medical doctors I believe were a bit frowned on compared to the PhD/D. Phils